Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT05343858 Completed - Metabolic Syndrome Clinical Trials

Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome

ALGAENERGY
Start date: September 9, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of the consumption of two microalgae Chlorella vulgaris and Arthrospira platensis (Spirulina) on some biomarkers of metabolic syndrome: Total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, Apolipoprotein A and Apolipoprotein B, in overweight / obese subjects with altered lipid profile.

NCT ID: NCT05343572 Recruiting - Clinical trials for Recurrent Implantation Failure

Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium

Start date: November 1, 2023
Phase: Early Phase 1
Study type: Interventional

This study will assess the use of autologous bone marrow stem cells mobilization using 1,1'-[1,4-phenylenebis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane (PLERIXAFOR) as an effective medical therapy for the treatment of Asherman's Syndrome (AS), Atrophic Endometrium (AE) and Recurrent Implantation Failure (RIF).

NCT ID: NCT05343468 Completed - Quality of Life Clinical Trials

Life Skills Improved in Children With Down Syndrome After Using Assistive Technology

Start date: September 20, 2020
Phase: N/A
Study type: Interventional

Enhancing independence and quality of life are key modifiable outcomes that are short- and long-term goals for children with Down syndrome (DS) and for their parents. The study investigated the efficacy of assistive technology in improving children with Down Syndrome's independence and quality of life. Using a commercially available assistive technology, the MapHabit system, the investigators implemented the software with participants' families for 4 weeks. The investigators hypothesized that the assistive technology will improve adaptive behavioral skills and overall quality of life.

NCT ID: NCT05343351 Completed - Pain Clinical Trials

Effect of Out of Plane and In Plane Injection Techniques in Patients With Carpal Tunnel Syndrome

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study, using two different injection techniques, 1. To evaluate the patients in terms of the pain they feel during the application of carpal tunnel syndrome (CTS) injection, 2. Evaluation in terms of undesirable effects developing after injection, 3. To evaluate the degree of pain/drowsiness, symptom severity and functionality, and median nerve diameter at the end of the first month after the injection, and to evaluate the relationship of these parameters with the pain felt by the patients during the injection.

NCT ID: NCT05341648 Completed - COVID-19 Clinical Trials

Aerobic Exercise and Covid-19 Survivors With Post-Intensive Care Syndrome (Pics)

Start date: April 30, 2022
Phase: N/A
Study type: Interventional

To investigate the effects of aerobic exercise program on physical activity, aerobic capacity, anxiety& depression in Covid-19 survivors discharged from Intensive Care Unit. There is evidence in the literature that post-intensive case survivors who have been mechanically ventilated will likely experience short- and medium-term consequences in the form of Post Intensive Care Syndrome (PICS).

NCT ID: NCT05341362 Recruiting - Clinical trials for Supine Hypotensive Syndrome

Hemodynamic Management in Women With SHS

Start date: April 17, 2022
Phase: N/A
Study type: Interventional

Supine hypotensive syndrome often occurs following spinal anesthesia for cesarean delivery.In our study we base the regulation and drug administration both on the regular monitor and on a novel monitor which reflects upon the hemodynamic changes. Our aim is to observe whether the outcome of SHS patients with anesthesia management based on hemodynamic figures differs from those based on experience.

NCT ID: NCT05340816 Enrolling by invitation - Clinical trials for Premenstrual Syndrome

The Effects of Manual Lymphatic Drainage and Transcutaneous Electrical Nerve Stimulation in Premenstrual Syndrome

Start date: April 4, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to (a) investigate the effects of manual lymphatic drainage and transcutaneous electrical nerve stimulation on the severity of syndrome symptoms, pain, heart rate variability, and quality of life in women with premenstrual syndrome, and (b) compare the effectiveness of these two methods. Female participants who met the inclusion criteria and volunteered to participate in the study will be called approximately one week before menstruation. After the participants are randomly divided into 3 groups, their baseline assessments will be made. Then, the participants will be treated according to the group they are assigned to. Treatments will be applied for 5 days and once a day. No treatment will be applied to the control group. The assessments will be repeated after the treatment, on 1st day of menstruation, two days before the next menstruation, and on the first day of the next menstruation. The hypothesis of this study is that manual lymphatic drainage and transcutaneous electrical nerve stimulation have positive effects on the severity of premenstrual syndrome symptoms, pain, heart rate variability, and quality of life.

NCT ID: NCT05340634 Completed - Clinical trials for Polycystic Ovary Syndrome

Evaluation of Metionac for the Modulation of Metabolic and Endocrine Parameters in Patients With PCOS.

Start date: April 20, 2020
Phase: Phase 4
Study type: Interventional

Evaluate the efficacy of the combination of antioxidants ALA, NAC, Vit. B6 and SAMe as a dietary supplement, in the improvement of metabolic and endocrine parameters and clinical manifestations of PCOS.

NCT ID: NCT05340400 Completed - Clinical trials for Irritable Bowel Syndrome

The Prevalence and Risk Factors of Irritable Bowel Syndrome Among Adults

Start date: April 25, 2022
Phase:
Study type: Observational

This is a multicenter cross-sectional study on the prevalence of Irritable Bowel Syndrome and the risk factors associated with it. The Rome IV criteria is used for diagnosing IBS. A questionnaire-guided interview will be applied to all subjects.

NCT ID: NCT05339529 Recruiting - Clinical trials for Acute Aortic Syndrome

Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Thymosin α1) V

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) are the major causes of death in patients with acute aortic syndrome (AAS). Therefore, the prevention of SIRS and MODS is of great clinical value, and immunomodulatory therapy with thymosin alpha 1 may be beneficial. This study was designed to test the hypothesis that the administration of thymosin alpha 1 during the acute phase of AAS will result in a reduced incidence of SIRS and MODS.